The trial was approved in preparation for another Gujarat company, Corona

 The trial was approved in preparation for another Gujarat company, Corona

Resen Pharmaceuticals, an associate company of Alembic Pharmaceuticals in Vadodara, has been granted a human trial by the US Food and Drug Administration.

Ravi Agarwal / Vadodara: Another company from Gujarat is preparing to bring corona drug in the market. Vadodara-based Alembic Group's Rezen Company has received approval for a trial of Corona's oral drug. His human trial will take place in the United States under the supervision of the US FDA. But the medicine will be made in Vadodara only in Alembic company. If the first phase clinical trial is successful, Corona's drug will also be on the market.

Resen Pharmaceuticals, an associate company of Alembic Pharmaceuticals in Vadodara, has been granted a human trial by the US Food and Drug Administration. The trial of this oral drug will take place in America. This associate company of Alembic Company will conduct a trial on volunteers. The company also announced that the FDA had responded positively to the new drug before the US FDA. It has been claimed by the company to be safe and without side effects in pre-clinic studies.

The drug made for the trial has been manufactured at the Alembic Company in Vadodara. However, the company is likely to bring this drug to market soon. Raisen's drug trial is set to begin in December. According to the company, this is an oral antiviral drug. Whose clinical trial will begin in the United States?

Click Here To Read News Report 

Prime Minister Narendra Modi recently visited the Serum Institute of India in Pune, Bharat Biotech in Hyderabad, and Cadila Healthcare in Ahmedabad to get an idea of ​​the vaccine being developed.